All NICE articles
-
NewsNew draft guideline recommends all employers give mental health training to managers
The joint NICE and Public Health England guidance recommends that all managers should be given the skills to support employees with mental health issues
-
News
Nivolumab to be routinely available on the NHS for head and neck carcinoma
The NICE draft guidance appraisal committee concluded that nivolumab meets the criteria to be considered a cost-effective, life-extending treatment at the end of life
-
News
Professor Gillian Leng to retire as NICE Chief Executive
Chief Executive Professor Gillian Leng has announced she is to retire from NICE after 20 years
-
News
NICE recommends JAK inhibitor for people with juvenile idiopathic arthritis
According to NICE, the evidence shows that tofacitinib is effective compared with placebo and it has a similar effect to other treatments for the same indication
-
NICE guideline
NICE C. difficile prescribing guideline
Antimicrobial prescribing strategy for managing C. difficile infection in adults, young people, and children
-
News
NICE publishes guideline on the healthcare experiences of babies, children, and young people
New NICE guidance advises empowering children and young people to take an active role in their healthcare
-
News
NICE publishes an update to guidance on chronic kidney disease
Updated NICE guideline covers investigation and treatment of chronic kidney disease and associated disorders
-
News
New guidance on obstructive breathing disorders published by NICE
NICE guideline 202 covers investigation and management of obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
-
News
NICE recommends abemaciclib for advanced breast cancer
New draft guidance from NICE recommends twice-daily abemaciclib with fulvestrant for adults with hormone receptor-positive, HER2-negative breast cancer
-
News
First drug approved under NICE fast-track pilot scheme
The fast-track appraisal process is being piloted by NICE for the review of selected low-risk appraisals
-
News
COVID-19 rapid guideline on haematopoietic stem cell transplantation updated by NICE
The updated guidance recommends the use of PCR testing before conditioning therapy, and a repeat respiratory review following COVID-19 infection
-
News
New technology appraisal guidance published on biologic treatments for RA
The NICE guidance covers adalimumab, etanercept, infliximab, and abatacept for moderate rheumatoid arthritis after conventional disease-modifying anti-rheumatic drugs have failed
-
News
NICE sets out new 5-year strategy
NICE’s new strategy to 2026 sets out the institute’s ambitious vision for the future
-
NICE guideline
NICE bipolar disorder guideline
A useful summary of NICE guidance on the assessment and management of bipolar disorder in adults, children and young people in primary care
-
NICE guideline
NICE guideline on the treatment of human and animal bites
This NICE guideline summary sets out an antimicrobial prescribing strategy for human and animal bites (excluding insect bites) in adults, young people and children aged 72 hours and over
-
NICE guideline
NICE antimicrobial prescribing guideline for insect bites and stings
This Guidelines summary covers an antimicrobial prescribing strategy for insect and spider bites and stings in adults, young people, and children
